Lexaria Bioscience Corp. (NASDAQ: LEXX) announced on April 30, 2026, the launch of an ongoing investor video series aimed at expanding shareholder communications. The series will feature interviews with management and updates on the company's drug delivery technology platform.
The first video in the series is now available on the company's website and YouTube channel. It includes a discussion with CEO Chris Bunka about recent developments, including the company's DehydraTECH technology used to improve the bioavailability of active pharmaceutical ingredients.
Lexaria stated that the series will be updated regularly to keep investors informed about corporate milestones, clinical trial progress, and strategic partnerships. The initiative is part of a broader effort to increase transparency and engagement with the investment community.
